FA
PFE icon

Fountainhead AM’s Pfizer PFE Stock Holding History

Fountainhead AM’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1K Buy
1,249
+312
+33% +$8.16K 0.02% 166
2026
Q1 		$26.3K Buy
937
+723
+338% +$19.2K 0.02% 170
2025
Q4 		$5.33K Sell
214
-20,864
-99% -$526K 0.01% 145
2025
Q3 		$537K Sell
21,078
-346
-2% -$8.54K 0.07% 109
2025
Q2 		$519K Buy
21,424
+976
+5% +$22.8K 0.08% 112
2025
Q1 		$518K Buy
20,448
+922
+5% +$24.1K 0.08% 88
2024
Q4 		$518K Buy
19,526
+247
+1% +$6.7K 0.09% 82
2024
Q3 		$558K Sell
19,279
-65
-0.3% -$1.9K 0.12% 70
2024
Q2 		$541K Buy
19,344
+118
+0.6% +$3.25K 0.13% 63
2024
Q1 		$534K Buy
19,226
+75
+0.4% +$2.08K 0.13% 62
2023
Q4 		$551K Buy
+19,151
New +$579K 0.15% 57

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fountainhead AM's PFE Position: Q2 2026 in Review

Fountainhead AM increased its Pfizer (PFE) stake by 33% in Q2 2026, buying an estimated $8.16K and bringing the position to 1,249 shares worth $30.1K. The position accounts for 0.02% of the portfolio, ranked #166.

Fountainhead AM first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $558K in Q3 2024. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fountainhead AM held 1,249 shares of Pfizer worth $30.1K as of Q2 2026.
  • Fountainhead AM bought 312 Pfizer shares in Q2 2026, an estimated $8.16K.
  • Pfizer made up 0.02% of Fountainhead AM's portfolio in Q2 2026, its #166 holding.
  • Fountainhead AM first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Fountainhead AM's Pfizer position peaked at $558K in Q3 2024.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fountainhead AM's 13F filing for Q2 2026, filed 3 Aug 2026.